Mesoblast gets FDA go ahead for pediatric drug

The US Food and Drug Administration has told biotechnology company Mesoblast that it now has sufficient clinical data to support a submission to approve the company’s remestemcel-L drug for treatment of pediatric patients. Remestemcel-L is being developed for inflammatory diseases in children and adults, including steroid-refractory acute graft versus host disease, and biologic-resistant inflammatory bowel…

AUKUS innovation challenge targets electronic warfare

The first in a series of AUKUS Innovation Challenges, the AUKUS Electronic Warfare Innovation Challenge, has been launched today through the Advanced Strategic Capabilities Accelerator (ASCA). The first AUKUS Challenge will seek innovative solutions to shared electronic warfare challenges from industry and research institutions in Australia, the United Kingdom and United States. ASCA will lead…

Titomic in biggest-ever sale of 3D printers – destined for Ukraine

Additive manufacturing machinery manufacturer Titomic has announced its largest-ever order for D523 cold spray metal printing systems to the Royal Netherlands Army, the Koninklijke Landmacht. The order comprises 10 units of the D523 low pressure system with a total sale value of $1.28 million, marking a significant milestone in Titomic’s expansion in the defence sector.…

Quickstep launches engineering services business

Composites manufacturer Quickstep has launched Quickstep Engineering Solutions allowing companies to benefit from its product development and manufacturing skills. CEO and Managing Director Mark Burgess said the company was thrilled to have productised ‘our incredible engineering offering – product and process design/development, industrial automation and supporting capabilities’. Burgess said: “With over 20 years of expertise…